In short
Overview
The cost of medical weight loss in Dubai is driven by the medicine and by how long treatment lasts. This page shows what makes up the total and how to compare quotes.
Direct Answer
The cost of medical weight loss in Dubai has 3 parts: the consultation with assessment, the medicine and the monitoring. The medicine is the largest part, because tirzepatide and semaglutide have no generic versions.
Duration is the part most often left out: stopping treatment leads to a regain of about 0.4 kg a month, with a return to the starting weight within about 2 years, in a meta-analysis of 37 studies with over 9,300 people. Dr Felix explains every cost before it arises; no prices are published, because the plan depends on the medicine that fits you.
Who This Applies To
- People planning a full year of treatment, not one month.
- People comparing a low monthly price that leaves out monitoring.
- People with a modest weight loss goal.
- People already on a weight loss medicine elsewhere.
Option Comparison / Decision Criteria
What drives the total cost of medical weight loss?
The total cost is driven by 5 factors, set out in the table.
| Factor | Effect on cost |
|---|---|
| Choice of medicine | Tirzepatide and semaglutide are the most effective and the most expensive |
| Dose reached | Higher doses cost more; the lowest dose that reaches the goal is used |
| Weight loss goal | A goal under 15 percent is often reached with less expensive medicines |
| Monitoring | Contact every 4 to 6 weeks at first, then every 2 to 3 months |
| Duration | Long-term treatment, because weight returns after stopping |
How does the weight loss goal change the cost?
A goal of 15 percent or more, 15 kg at 100 kg, normally needs tirzepatide or semaglutide. A goal under 15 percent is often reached with liraglutide or orforglipron, the less expensive and less effective options, according to clinical guidance.
Why an In-Person Physician Review Matters
Why does the 12-week review save money?
Planned reviews help avoid ineffective treatment because an insufficient response leads to review of treatment duration, tolerability and the continuation criteria for the particular medicine. That prevents paying for a medicine that does not work. A medicine that causes weight gain, for example some medicines for diabetes or depression, is reviewed as well, which sometimes addresses part of the problem without a new prescription.
Frequently Asked Questions
Tirzepatide and semaglutide have no generic versions, so the medicine is the largest part of the cost.
Yes, for a goal under 15 percent liraglutide or orforglipron often reach the target at a lower cost.
Treatment is long term, because weight returns at about 0.4 kg a month after stopping.
Response and tolerability are reviewed at an agreed interval. The prescriber applies the continuation criteria for the particular medicine before deciding whether to change it.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Overweight and obesity management (NG246)
- Wegovy: European public assessment report
- Mounjaro KwikPen: Summary of Product Characteristics
- UAE weight loss drug crackdown: 71 sources, 14 influencers face action
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.